XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 174,700 $ 181,159
Accounts receivable, less allowance for doubtful accounts of $1,284 and $1,525 148,727 140,562
Contract assets 21,933 0
Inventories 117,739 112,557
Prepaid income taxes 2,732 3,087
Current portion of asbestos-related insurance receivables 5,682 5,682
Assets held for sale 381 896
Other current assets 13,535 10,580
Total current assets 485,429 454,523
Property, plant and equipment, net of accumulated depreciation of $300,416 and $289,909 184,478 179,611
Investments in unconsolidated joint ventures 19,411 18,324
Deferred income taxes 3,501 6,008
Goodwill 234,287 237,107
Other intangible assets, net of amortization 152,009 160,278
Asbestos-related insurance receivables 63,511 63,511
Other long-term assets 5,503 5,772
Total assets 1,148,129 1,125,134
Current liabilities    
Accounts payable 37,299 36,116
Accrued employee benefits and compensation 26,081 39,394
Accrued income taxes payable 3,987 6,408
Current portion of capital lease obligations 600 579
Current portion of asbestos-related liabilities 5,682 5,682
Other accrued liabilities 25,095 25,629
Total current liabilities 98,744 113,808
Borrowings under credit facility 130,982 130,982
Non-current portion of capital lease obligations 5,404 5,873
Pension liability 8,720 8,720
Retiree health care and life insurance benefits 1,685 1,685
Asbestos-related liabilities 70,056 70,500
Non-current income tax 9,755 12,823
Deferred income taxes 13,879 10,706
Other long-term liabilities 4,119 3,464
Commitments and contingencies (Note 14)
Shareholders’ equity    
Capital Stock - $1 par value; 50,000 authorized shares; 18,380 and 18,255 shares issued and outstanding 18,380 18,255
Additional paid-in capital 126,452 128,933
Retained earnings 732,217 684,540
Accumulated other comprehensive loss (72,264) (65,155)
Total shareholders' equity 804,785 766,573
Total liabilities and shareholders' equity $ 1,148,129 $ 1,125,134